Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nventa Biopharmaceuticals

1990 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of therapeutics and drug delivery technologies. The company engages in the development of therapeutics for the treatment of viral infections and cancers, with a focus on diseases caused by the human papillomavirus.

Formerly Known As
StressGen Biotechnologies
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Acquirer
Akela Pharma
Primary Office
  • 9381 Judicial Drive
  • Suite 180
  • San Diego, CA 92121
  • United States

Nventa Biopharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Nventa Biopharmaceuticals‘s full profile, request access.

Request full access to PitchBook